QuantumCell commits $2.2bn on AlzeCure’s Alzheimer’s platform
QuantumCell has announced a significant investment of $2.2 billion in AlzeCure’s innovative platform targeting Alzheimer’s disease. This financial commitment underscores the growing urgency within the pharmaceutical industry to address the challenges posed by neurodegenerative disorders, particularly as the global population ages and the prevalence of Alzheimer’s increases. The lead product from AlzeCure’s platform has already…









